Quantified Clinical Risk Change as an End Point During Prostate Cancer Active Surveillance.


For men with low-stage prostate cancer (PCa) managed with active surveillance (AS), clinical thresholds for intervention have not been definitively established. We aimed to evaluate whether the magnitude of quantitative risk change may serve as a refined end point. We identified 735 men managed with AS at our institution who received a minimum of two… (More)
DOI: 10.1016/j.eururo.2016.04.021

2 Figures and Tables


  • Presentations referencing similar topics